1,023 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Adverum Competitors or Alternatives

Adverum's top competitors include Stuart Therapeutics, EyeBio and ONL Therapeutics.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Adverum's company profile

Laurent Fischer

President & CEO

86/100
190
$685.4M
$ < 1M
  • $685.4M
    $ < 1M
  • 190
    $685.4M
  • $ < 1M
  • 86/100
  • 190
  • $685.4M
  • $ < 1M
View ProfileView
1
Adverum's Competitor - Stuart Therapeutics logo

Eric Schlumpf

President & CEO

- -
$11M
  • $11M
  • $11M
  • - -
  • $11M
View ProfileView
2
Adverum's Competitor - EyeBio logo

David Guyer

President & CEO

90/100
1 - 25
$130M
$100K - 5M
  • $130M
    $100K - 5M
  • 1 - 25
    $130M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $130M
  • $100K - 5M
View ProfileView
3
Adverum's Competitor - ONL Therapeutics logo

David Esposito

President & CEO

88/100
25 - 100
$149.2M
$5M - 25M
  • $149.2M
    $5M - 25M
  • 25 - 100
    $149.2M
  • $5M - 25M
  • 88/100
  • 25 - 100
  • $149.2M
  • $5M - 25M
View ProfileView
4
Adverum's Competitor - AGTC logo

Sue Washer

President & CEO

75/100
100 - 250
$87.5M
$100K - 5M
  • $87.5M
    $100K - 5M
  • 100 - 250
    $87.5M
  • $100K - 5M
  • 75/100
  • 100 - 250
  • $87.5M
  • $100K - 5M
View ProfileView
5
Adverum's Competitor - Spark Therapeutics logo

Sylke Poehling

CEO

82/100
500 - 1,000
$886.2M
$25M - 100M
  • $886.2M
    $25M - 100M
  • 500 - 1,000
    $886.2M
  • $25M - 100M
  • 82/100
  • 500 - 1,000
  • $886.2M
  • $25M - 100M
View ProfileView
Adverum's top 15 competitors are Stuart Therapeutics, EyeBio, ONL Therapeutics, bluebird bio, AGTC, Spark Therapeutics, Intellia, 4DMT, Strongbridge Biopharma, Sangamo, Just., Cycle Pharmaceuticals, Complement Therapeutics, CRISPR and uniQure. Together they have raised over 4.5B between their estimated 3.5K employees. Adverum has 190 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 247.

Adverum VS EyeBio

EyeBio is Adverum's #2 rival. EyeBio is a Private company that was founded in 2021 in London, England. EyeBio competes in the Biotechnology field. Compared to Adverum, EyeBio has 183 fewer employees.

Adverum VS ONL Therapeutics

ONL Therapeutics is one of Adverum's top competitors. ONL Therapeutics's headquarters is in Ann Arbor, Michigan, and was founded in 2006. Like Adverum, ONL Therapeutics also operates in the Biotechnology industry. ONL Therapeutics generates 1,190% of Adverum's revenue.

Looking for similar companies to Adverum?

Similar Companies

Biotechnology companies in Redwood City

See 48 companies 
Companies in Redwood City with employees in 100-250 range

See 184 companies 
Pharmaceuticals & Biotechnology companies in Redwood City

See 60 companies 
Companies in Redwood City with revenue in $100K-5.0M range

See 482 companies 
Biotechnology companies with employees in 100-250 range

See 1,110 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Pharmaceuticals & Biotechnology companies with employees in 100-250 range

See 1,805 companies 
Biotechnology companies in California

See 3,096 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Adverum and Adverum's Competitors

April 15, 2025Yahoo
In This Article: REDWOOD CITY, Calif. (AP) - REDWOOD CITY, Calif. (AP) - Adverum Biotechnologies Inc. (ADVM) on Tuesday reported a loss of $40.9 millio...
April 15, 2025Benzinga
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Intellia Therapeutics, Inc. (NASDAQ:NTLA...
April 15, 2025Medthority
Eisai provides update on European Commission's regulatory review of Lecanemab for early Alzheimer's....
April 15, 2025Owler
Adverum’s revenue had no change from 1M to Sep 2024....
April 15, 2025FinanzNachrichten
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild ...

Frequently Asked Questions about Adverum

  1. Who are Adverum's top competitors?

    Adverum's top 3 competitors are Stuart Therapeutics, EyeBio, ONL Therapeutics.

  2. Who is similar to Adverum?

    Stuart Therapeutics is the most similar to Adverum. EyeBio and ONL Therapeutics are also similar to Adverum.

  1. Are Adverum and Stuart Therapeutics competitors?

    Yes, Stuart Therapeutics is one of Adverum’s top competitors.